Category: Side Effect: Nerve Damage (peripheral neuropathy, nerve disorders)
-
Xeljanz: Drug-induced Peripheral Neuropathy as Possible Xeljanz Side Effect in 2 RA Patients
Reports of Rheumatoid Arthritis Patients on Xeljanz Experiencing Secondary Neurological Adverse Events (Posted by Tom Lamb at Drug Injury Watch) As we have written about previously, according to the FDA, some of the generally recognized…
-
Gadolinium-Based Contrast Agents: Gadolinium Retention Higher For Linear Gadolinium Agents Than Macrocyclic Agents
Gadolinium Retention Can Cause Various Medical Problems With General Diagnosis Label Of Gadolinium Deposition Disease (Posted by Tom Lamb at DrugInjuryWatch.com) There are two types of gadolinium based contrast agents (GBCAs): linear and…
-
Gadolinium Retention Warnings Added To Drug Labels For Gadolinium Contrast Agents Used During MRI / MRA
Label Changes Announced By FDA In December 2017 Finally Approved For Magnevist, Omniscan, And Other GBCAs In April 2018 (Posted by Tom Lamb at DrugInjuryWatch.com) Gadolinium based contrast agents (GBCAs) are substances…
-
Iclusig: Leukemia Drug With Many Different Serious Side Effects Had More Warnings Added In November 2016
Black-Box Warning Now Includes Venous Thromboembolism As Well As Various Types Of Arterial Occlusions, And There Are More New Safety Issues (Posted by Tom Lamb at DrugInjuryWatch.com) Iclusig (ponatinib) is a kinase…
-
Fluoroquinolone Antibiotics Cipro, Avelox, And Levaquin Linked To Peripheral Neuropathy In First Large Epidemiologic Study
Neurology Medical Journal Article Reports Two-Times Increased Risk For This Nerve Damage Side Effect For New Users Of These Antibiotics (Posted by Tom Lamb at DrugInjuryWatch.com) The popular antibiotics Levaquin (levofloxacin), Cipro (ciprofloxacin), Avelox (moxifloxacin) are…
-
Serious Nerve Damage Side Effect Peripheral Neuropathy Associated With Levaquin, Cipro, And Avelox May Be A Permanent Drug Injury
An August 2013 Label Change Mandated By The FDA For All Fluoroquinolone Antibiotics Was Intended To Raise The Profile Of This Relatively Unknown Risk (Posted by Tom Lamb at DrugInjuryWatch.com) _________________________________________________________________________ UPDATE: Fluoroquinolone Antibiotics…